Clinical Trial Update: N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates on N-acetyl cysteine for chemotherapy-induced peripheral neuropathy in cancer patients (Phase 1/Phase 2; completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathy
• Peripheral Neuropathy Due to Chemotherapy

Drugs mentioned

• N-Acetyl-Cysteine (N-acetylcysteine)

Snippet

Sponsor: Ain Shams University | Conditions: Peripheral Neuropathy Due to Chemotherapy | Phase 1, Phase 2 | Status: COMPLETED